Items where Author is "Escribano, P."

Article

Gaine, S. P. and Escribano, P. and Muller, A. and Klement, R. and Söderberg, S. and Lange, T. J. (2022) Selexipag Experience in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Real-World Experience from EXPOSURE. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 205: A4914. ISSN 1073-449X, 1535-4970

Conference or Workshop Item

Soderberg, S. and Gaine, S. and Muller, A. and Klement, R. and Lange, T. and Escribano, P. (2022) Characterisation of pulmonary arterial hypertension patients with cardiovascular comorbidities treated with selexipag: real-world evidence from the EXPOSURE study. In: ESC Congress 2022, 26. - 29. August 2022, Barcelona, Spain.

Escribano, P. and Gaine, S. and Klement, R. and Muller, A. and Lange, T. J. and Soderberg, S. (2022) Pulmonary arterial hypertension associated with congenital heart disease: real-world analysis of clinical characteristics, treatment patterns and outcomes from EXPOSURE. In: ESC Congress 2022, 26. - 29. August 2022, Barcelona, Spain.

Escribano, P. and Gaine, S. and Biedermann, P. and Muller, A. and Valge, M. and Lange, T. and Soderberg, S. (2021) Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE. In: 41st Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), APR 24 - 28, 2021, Toronto, Canada, hybrid.

Johnson, M. K. and Lange, T. J. and Söderberg, S. and Biedermann, P. and Muller, A. and Luik, K. and Escribano, P. and Gaine, S. (2021) SELEXIPAG TITRATION AND DOSING PATTERNS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN A REAL-WORLD CLINICAL SETTING: INSIGHTS FROM THE EXPOSURE STUDY. In: British Thoracic Society Winter Meeting 2021, Wednesday 24 to Friday 26 November 2021, Online.

Lange, T. J. and Söderberg, S. and Biedermann, P. and Müller, A. and Luik, K. and Escribano, P. and Gaine, S. P. (2021) Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study. In: International Conference of the American Thoracic Society (ATS), MAY 14-19, 2021, Virtual.

Lange, T. J. and Escribano, P. and Biedermann, P. and Muller, A. and Sun, H. and Söderberg, S. and Gaine, S. (2020) Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study. In: International Conference of the American Thoracic Society, 2020, ELECTR NETWORK.

Other

Muller, A. and Soderberg, S. and Escribano, P. and Biedermann, P. and Sun, H. and Lange, T. J. and Gaine, S. (2019) REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE). ELSEVIER SCIENCE INC, NEW YORK.

Hoeper, M. and Gall, H. and Gruenig, E. and Klose, H. and Halank, M. and Langleben, D. and Snijder, R. J. and Escribano, P. and Mielniczuk, L. M. and Lange, T. and Vachiery, J. E. and Wirtz, H. and Helmersen, D. S. and Tsangaris, I. and Barbera, J. A. and Pepke-Zaba, J. and Boonstra, A. and Rosenkranz, S. and Ulrich, S. and Steringer-Mascherbauer, R. and Sanchez, M. A. Gomez and Humbert, M. and Pittrow, D. and Simonneau, G. and Klotsche, J. and Williams, E. and Meier, C. and Ghofrani, H. A. (2019) Safety of Riociguat for the Treatment of Pulmonary Arterial Hypertension: Final Data Cut from the EXPERT Registry. AMER THORACIC SOC, NEW YORK.

Klose, H. and Gall, H. and Ghofrani, H. and Gruenig, E. and Humbert, M. and Simonneau, G. and Halank, M. and Langleben, D. and Snijder, R. J. and Escribano, P. and Mielniczuk, L. M. and Lange, T. and Vachiery, J. and Wirtz, H. and Helmersen, D. S. and Tsangaris, I. and Barbera, J. A. and Pepke-Zaba, J. and Boonstra, A. and Rosenkranz, S. and Ulrich, S. and Mascherbauer, R. and Delcroix, M. and Jansa, P. and Gomez Sanchez, M. A. and Klotsche, J. and Meier, C. and Pittrow, D. and Hoeper, M. M. (2018) Riociguat for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Update from the EXPERT Registry. AMER THORACIC SOC, NEW YORK.

Klose, H. and Gall, H. and Ghofrani, H. -A. and Hoeper, M. M. and Grunig, E. and Halank, M. and Vachiery, J. and Wirtz, H. and Mielniczuk, L. M. and Lange, T. J. and Helmersen, D. S. and Pepke-Zaba, J. and Langleben, D. and Barbera, J. A. and Escribano, P. and Mascherbauer, R. and Delcroix, M. and Tsangaris, I. and Boonstra, A. and Snijder, R. J. and Nielsen-Kudsk, J. E. and Cottin, V. and Ulrich, S. and Corris, P. A. and Simonneau, G. and Gomez Sanchez, M. -A. and Klotsche, J. and Pittrow, D. and Meier, C. and Humbert, M. (2017) Riociguat For The Treatment Of Pulmonary Hypertension: Safety Data From The Expert Registry. AMER THORACIC SOC, NEW YORK.